Literature DB >> 18338775

Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993.

Geir Aamodt1, Jørgen Jahnsen, May-Bente Bengtson, Bjørn Moum, Morten H Vatn.   

Abstract

BACKGROUND: The purpose was to study the spatial distribution of cases of inflammatory bowel disease (IBD) and characterize municipalities with high incidences in a search for environmental risk factors.
METHODS: Spatial clustering of patients diagnosed with IBD during 1990-1993 were studied in 4 counties in southeastern Norway, and an ecological analysis was conducted to study the relationship between risk of IBD in the municipalities and their characteristics such as population, health care, urban/rural change, and socioeconomic change.
RESULTS: One cluster consisting of 4 municipalities was identified for IBD in Østfold county (P = 0.011). The ecological analysis showed that the incidence rate of IBD was 33% (95% confidence interval [CI]: 2%-75%) higher in municipalities with the highest level of education compared to the lowest level of education and 35% (2%-78%) higher in urban than rural municipalities. The incidence rate was 11% (1%-20%) lower in municipalities with a high urban/rural change compared to municipalities with low urban/rural change. Individuals living in high-risk municipalities were 3 times (1.57-5.45) more likely to have a first-degree family member with IBD than individuals living in normal-risk municipalities.
CONCLUSIONS: The geographic distribution of cases with IBD is not uniformly distributed and is related to urbanization, level of education, and moving pattern. Geographic distribution may be explained by either changes in environment-host relationships or neurobiological mechanisms due to stress and economic frustration. These factors and genetic predisposition might also explain increased familial clustering. Spatial clustering was significant neither for Crohn's disease CD nor ulcerative colitis (UC) but showed a stronger tendency within the CD group.

Entities:  

Mesh:

Year:  2008        PMID: 18338775     DOI: 10.1002/ibd.20417

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

1.  Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.

Authors:  Jonathan M Spergel; Wendy M Book; Elizabeth Mays; Lihal Song; Samir S Shah; Nicholas J Talley; Peter A Bonis
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

2.  Geographical variation of Crohn's disease residual incidence in the Province of Quebec, Canada.

Authors:  Pascal Michel; Laurie St-Onge; Anne-Marie Lowe; Michel Bigras-Poulin; Paul Brassard
Journal:  Int J Health Geogr       Date:  2010-05-12       Impact factor: 3.918

3.  A changing trend in the management of patients with newly diagnosed Crohn's disease.

Authors:  A Qasim; N Ullah; P Crotty; N Swan; N Breslin; B Ryan; W Torreggiani; E Eguare; P Neary; H O'Connor; C O'Morain
Journal:  Ir J Med Sci       Date:  2011-03-23       Impact factor: 1.568

4.  Chitin protects the gut epithelial barrier in a protochordate model of DSS-induced colitis.

Authors:  Assunta Liberti; Ivana Zucchetti; Daniela Melillo; Diana Skapura; Yoshimi Shibata; Rosaria De Santis; Maria Rosaria Pinto; Gary W Litman; Larry J Dishaw
Journal:  Biol Open       Date:  2018-01-17       Impact factor: 2.422

5.  Can temperature explain the latitudinal gradient of ulcerative colitis? Cohort of Norway.

Authors:  Geir Aamodt; May-Bente Bengtson; Morten H Vatn
Journal:  BMC Public Health       Date:  2013-05-31       Impact factor: 3.295

6.  Urolithiasis and crohn's disease.

Authors:  Sandro Roberto da Silva Gaspar; Tiago Mendonça; Pedro Oliveira; Tiago Oliveira; José Dias; Tomé Lopes
Journal:  Urol Ann       Date:  2016 Jul-Sep

7.  Exposure to Ambient Air Pollution and the Risk of Inflammatory Bowel Disease: A European Nested Case-Control Study.

Authors:  Jorrit L Opstelten; Rob M J Beelen; Max Leenders; Gerard Hoek; Bert Brunekreef; Fiona D M van Schaik; Peter D Siersema; Kirsten T Eriksen; Ole Raaschou-Nielsen; Anne Tjønneland; Kim Overvad; Marie-Christine Boutron-Ruault; Franck Carbonnel; Kees de Hoogh; Timothy J Key; Robert Luben; Simon S M Chan; Andrew R Hart; H Bas Bueno-de-Mesquita; Bas Oldenburg
Journal:  Dig Dis Sci       Date:  2016-07-26       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.